- Report
- October 2025
- 196 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 182 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 195 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 195 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 191 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 196 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 180 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 198 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 195 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 182 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 192 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 193 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 197 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 187 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 195 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 188 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 184 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 183 Pages
Global
From €4008EUR$4,500USD£3,478GBP
- Report
- August 2025
- 190 Pages
Global
From €4008EUR$4,500USD£3,478GBP
- Report
- January 2025
- 185 Pages
Global
From €4008EUR$4,500USD£3,478GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more